All In MedTech

Device Trial Radar · NCT02107495

Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting

Last checked: Nov 19, 2026Latest source record: Apr 19, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

191

Actual

Start

Mar 2014

Primary completion

Feb 2015

Study completion Feb 2015

Sponsor

Lead sponsor
Samsung ElectronicsNot on our public-company list
Sponsor type
Industry
Collaborators
Nexus DX
First posted
Apr 8, 2014

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To establish the performance characteristics of the Samsung LABGEO IVD-A20 CHF Test in intended use settings, by comparing test results of the A20 CHF Test with results obtained from an FDA-cleared comparator assay.

Conditions

  • Congestive Heart Failure

Interventions

  • Samsung LABGEO IVD-A20 CHF TestDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of clinically-confirmed CHF subjects for whom the Samsung LABGEO IVD-A20 CHF Test result was positive (clinical sensitivity).Time frame: baseline
  2. The proportion of non-CHF subjects for whom the LABGEO IVD A20 CHF Test result was negative (clinical specificity).Time frame: baseline
  3. Using a Passing-Bablok regression analysis, estimates of intercept and slope will be computed. Estimates of bias and corresponding 95% confidence interval for true bias at clinical decision threshold of 125mg/mL and 450 pg/mL will also be computed.Time frame: baseline

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of Maryland

    Baltimore, Maryland

  • Minneapolis Medical Research Foundation

    Minneapolis, Minnesota

  • Manassas Clinical Research Center

    Manassas, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.